Syndax(SNDX) - 2024 Q4 - Earnings Call Transcript

Syndax Pharmaceuticals (SNDX) Q4 2024 Earnings Call March 03, 2025 06:57 PM ET Company Participants Sharon Klahre - Vice President of Investor Relations & CommunicationsMichael Metzger - CEO & DirectorSteve Closter - CCONeil Gallagher - President, Head of Research & DevelopmentKeith Goldan - Chief Financial OfficerBradley Canino - DirectorKelly Shi - Senior Vice PresidentYigal Nochomovitz - DirectorDavid Dai - DirectorGeorge Farmer - Managing DirectorAnjali Ganguli - Chief Strategy OfficerErik Lavington - E ...